TELA Bio (TELA) Preferred Dividend Payments (2018 - 2019)
TELA Bio (TELA) posted Preferred Dividend Payments of $940000.0 for Q4 2019, down 54.32% on a QoQ basis from $2.1 million in Q3 2019, and down 52.41% year-over-year from $2.0 million in Q4 2018.
Powered by 
Analysis
TELA Bio (TELA) Preferred Dividend Payments (2018 - 2019) Analysis & Trends
TELA Bio has reported Preferred Dividend Payments for 2 years, with the latest figure at $940000.0 in Q4 2019.
- On a quarterly basis, Preferred Dividend Payments fell 52.41% year-over-year to $940000.0 in Q4 2019; TTM through Dec 2019 was $7.8 million, a N/A change from a year earlier, with the FY2019 full-year figure at $7.8 million, down 11.79% from the prior year.
- Preferred Dividend Payments was $940000.0 for Q4 2019 at TELA Bio, down from $2.1 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $2.8 million in Q2 2019, with the low at $940000.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | - |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | - |
| 10 | TELA Bio | 50.24 Mn | 19.82 Mn | 13.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 940,000.00 |
| Sep 30, 2019 | 2.06 Mn |
| Jun 30, 2019 | 2.76 Mn |
| Mar 31, 2019 | 2.03 Mn |
| Dec 31, 2018 | 1.98 Mn |
| Sep 30, 2018 | 1.87 Mn |